Press release
Brain Metastases Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)
DelveInsight's, "Brain Metastases Pipeline Insight 2024" report provides comprehensive insights about 40+ Brain Metastases companies and 45+ pipeline drugs in Brain Metastases pipeline landscape. It covers the Brain Metastases pipeline drug profiles, including clinical and nonclinical stage products. Brain Metastases pipeline report also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.Key Takeaways from the Brain Metastases Pipeline Report
* DelveInsight's Brain Metastases pipeline report depicts a robust space with 40+ active players working to develop 45+ pipeline therapies for Brain Metastases treatment.
* The leading companies working in the Brain Metastases Market include HUYA Bioscience, Kazia Therapeutics, BioMimetix, EpicentRx, Inc., Angiochem, Medolution Ltd., Betta Pharmaceuticals Co., Ltd., Merck Sharp & Dohme LLC, Bristol-Myers Squibb, 2-BBB Medicines, DEKK-TEC, Inc., Nascent Biotech, Quadriga Biosciences, Inc., Jubilant Therapeutics, Denali Therapeutics Inc, NUVATION BIO, Novocure GmbH, Affinia Therapeutics, Specialised Therapeutics, Precirix, Ashvattha Therapeutics, Cereius, Allarity Therapeutics, TYK Medicine, Surgimab, ORIC Pharmaceuticals, SonALAsense, Nerviano Medical Sciences, Lin Bioscience, Inc., Zai Lab, Lantern Pharma, ABM Therapeutics, Carthera , and others.
* Promising Brain Metastases Pipeline Therapies in the various stages of development include 8F fluciclovine, BT-M01, RRx-001 + WBRT, BMX-001, Veliparib, ANG1005, Keynatinib, and others.
* May 2024:- Emroy University- Pilot Study of Pembrolizumab and Stereotactic Radio-Surgery (SRS) for Patients With Melanoma or Non-Small Cell Lung Cancer (NSCLC) Brain Metastases (BM). This pilot trial studies the side effects of giving pembrolizumab together with stereotactic radiosurgery to treat patients with melanoma or non-small cell lung cancer that has spread to the brain. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.
Request a sample and discover the recent advances in Brain Metastases Treatment Drugs @ Brain Metastases Pipeline Outlook Report [https://www.delveinsight.com/sample-request/brain-metastases-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
In the Brain Metastases pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Brain metastases collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
Brain Metastases Overview
Brain metastases are a common complication of cancer and the most common type of brain tumor. Anywhere from 10% to 26% of patients who die from their cancer will develop brain metastases. While few cancers that metastasize to the brain can be cured using conventional therapies, long-term survival and palliation are possible with minimal adverse effects to patients. Increasingly, neuro-cognition and quality of life are being recognized as important endpoints for patients as survival continues to increase.
Find out more about Brain Metastases Therapeutics Assessment @ Brain Metastases Preclinical and Discovery Stage Products [https://www.delveinsight.com/sample-request/brain-metastases-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Brain Metastases Emerging Drugs Profile
* ANG1005: Angiochem
* Azeliragon: Cantex Pharmaceuticals, Inc.
* AZD3759: Alpha Biopharma Ltd.
Brain Metastases Pipeline Therapeutics Assessment
There are approx. 45+ key companies which are developing the therapies for Brain metastases. The Brain Metastases companies which have their Brain metastases drug candidates in the most advanced stage, i.e. phase III.
DelveInsight's Brain Metastases Pipeline Report covers around 45+ products under different phases of clinical development like
* Late stage products (Phase III)
* Mid-stage products (Phase II)
* Early-stage product (Phase I) along with the details of
* Pre-clinical and Discovery stage candidates
* Discontinued & Inactive candidates
Brain metastases pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
* Intra-articular
* Intraocular
* Intrathecal
* Intravenous
* Ophthalmic
* Oral
* Parenteral
* Subcutaneous
* Topical
* Transdermal
Brain Metastases Products have been categorized under various Molecule types such as
* Oligonucleotide
* Peptide
* Small molecule
Learn more about the emerging Brain Metastases Pipeline Therapies @ Brain Metastases Clinical Trials Assessment [https://www.delveinsight.com/sample-request/brain-metastases-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Brain Metastases Pipeline Report
* Coverage- Global
* Brain Metastases Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Brain Metastases Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
* Brain Metastases Companies- HUYA Bioscience, Kazia Therapeutics, BioMimetix, EpicentRx, Inc., Angiochem, Medolution Ltd., Betta Pharmaceuticals Co., Ltd., Merck Sharp & Dohme LLC, Bristol-Myers Squibb, 2-BBB Medicines, DEKK-TEC, Inc., Nascent Biotech, Quadriga Biosciences, Inc., Jubilant Therapeutics, Denali Therapeutics Inc, NUVATION BIO, Novocure GmbH, Affinia Therapeutics, Specialised Therapeutics, Precirix, Ashvattha Therapeutics, Cereius, Allarity Therapeutics, TYK Medicine, Surgimab, ORIC Pharmaceuticals, SonALAsense, Nerviano Medical Sciences, Lin Bioscience, Inc., Zai Lab, Lantern Pharma, ABM Therapeutics, Carthera , and others.
* Brain Metastases Pipeline Therapies- 8F fluciclovine, BT-M01, RRx-001 + WBRT, BMX-001, Veliparib, ANG1005, Keynatinib , and others.
Dive deep into rich insights for new drugs for Brain Metastases Treatment, Visit @ Brain Metastases Market Drivers and Barriers, and Future Perspective [https://www.delveinsight.com/sample-request/brain-metastases-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
* Introduction
* Executive Summary
* Brain metastases: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Brain metastases- DelveInsight's Analytical Perspective
* Late Stage Products (Phase III)
* ANG1005: Angiochem
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* Paxalisib: Kazia Therapeutics
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* MW151: ImmunoChem Therapeutics, LLC
* Drug profiles in the detailed report.....
* Preclinical and Discovery Stage Products
* JBI-2174: Jubilant Therapeutics
* Drug profiles in the detailed report.....
* Inactive Products
* Brain metastases Key Companies
* Brain metastases Key Products
* Brain metastases- Unmet Needs
* Brain metastases- Market Drivers and Barriers
* Brain metastases- Future Perspectives and Conclusion
* Brain metastases Analyst Views
* Brain metastases Key Companies
* Appendix
For further information on the Brain Metastases Pipeline therapeutics, reach out to Brain Metastases Unmet Needs and Analyst Views [https://www.delveinsight.com/sample-request/brain-metastases-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=brain-metastases-pipeline-fda-approvals-unmet-needs-preclinical-and-discovery-stage-product-and-companies-2024-updated]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Brain Metastases Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated) here
News-ID: 3496492 • Views: …
More Releases from ABNewswire

Bedrock Restoration - Water Fire Mold Damage Service, Expands Water Damage Repai …
Water Fire Mold Damage Service, a trusted provider of property restoration, has announced expanded service offerings to meet the growing demand for professional water damage solutions in the region. Known for their reliable, customer-focused approach, the company continues to support both homeowners and businesses in recovering from unexpected property damage caused by water, fire, or mold.
Responding to a Growing Need for Water Damage Restoration
Property owners across Minnesota are increasingly seeking…

Winkler Kurtz LLP Expands Resources to Handle Increased Demand for Personal Inju …
For individuals searching for personal injury attorneys, the expansion of Winkler Kurtz LLP's team means greater accessibility and reduced wait times for consultations. The firm's deep roots in the Port Jefferson Station community allow them to understand local nuances, such as common accident hotspots and specific regional legal precedents.
Port Jefferson Station has seen a notable rise in personal injury cases, driven by factors such as increased traffic congestion, construction activity,…

Protecting Property Value: Hose Bros Inc Highlights How Professional Power Washi …
For residents searching for power washing near me, Hose Bros Inc offers accessible and reliable services tailored to the Millsboro community. Their local expertise ensures an understanding of regional challenges, such as the impact of salt air on coastal properties or the tendency for humidity to promote mold growth in shaded areas. This knowledge allows them to customize their approach, selecting appropriate pressure levels and cleaning agents for different surfaces.
In…
![Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Prices](https://cdn.open-pr.com/9/1/914818326_g.jpg)
Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Price …
A 2025 cost guide to kitchen, bathroom, and full home remodeling in Tampa Bay, featuring expert insights from Craftline Remodeling on pricing, budgeting, and contractor selection.
Market Overview: Understanding Tampa Bay Remodeling Investment Trends
Tampa Bay's home remodeling market has experienced significant cost evolution in 2025, with project expenses varying dramatically across South Tampa, Carrollwood, Seminole Heights, Clearwater, St. Petersburg, and Wesley Chapel based on material choices, project scope, and contractor expertise.…
More Releases for Brain
Brain Training Apps Market Boosting the Brain: The Rise of Brain Training Apps a …
Brain Training Apps Market Assessment worth $ 44.43 Billion by 2030 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Brain Training Apps Market- by App Type (Memory, Attention, Language, Executive Function, Visual/spatial, and Other App Types), User Type (Android, iOS and Other User Types), Trends, Industry Competition Analysis, Revenue and Forecast To 2024-2031."
Get a free sample copy of…
Nutrient Survival Champions Brain Health During Alzheimer's & Brain Awareness Mo …
This June, Nutrient Survival is reminding people that nourishing your mind is as crucial as feeding your body, offering a revolutionary BrainCare® line.
Reno, NV (June 5, 2024) - As June marks Alzheimer's & Brain Awareness Month, Nutrient Survival, veteran-led pioneer in nutritional innovation, stands at the forefront of promoting
cognitive well-being with its revolutionary BrainCare® line and Brain Omega 3 Bar®. With alarming statistics highlighting the prevalence of brain-related ailments among…
Brain Monitoring Device Market - Harnessing the Power of Neurotechnology: Brain …
Newark, New Castle, USA: The "Brain Monitoring Device Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Brain Monitoring Device Market: https://www.growthplusreports.com/report/brain-monitoring-device-market/7889
This latest report researches the industry structure,…
Supercharge Your Brain: Revolutionary Brain Health Supplements for Improved Brai …
The global 𝐁𝐫𝐚𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐒𝐮𝐩𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐬 market is estimated to attain a significant valuation by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand during the forecast period, 2021-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the Brain Health Supplements industry. The current…
Global Wearable Brain Devices Market Growth by 2030 - Advanced Brain Monitoring …
The research report based on the Global Wearable Brain Devices Industry offers the detailed study of each and every aspect coupled with the Wearable Brain Devices market. The report also analyzes all the strategic developments made in the Wearable Brain Devices sector. The research report offers detailed and accurate numerical data on costs, revenues, sales, profits, etc. The market report narrowly analyzes all the key growth factors that are considered…
Retro X Focus Nootropic Brain Booster - SUPERCHARGED BRAIN PERFORMANCE!
Retro X Focus Nootropic Brain Booster is a state-of-the-art nootropic that employs vitamins, vital nutrients, plus amino acids to assist you to think quicker, cleverer, smarten your memory, and improve attention and leave you feeling invigorated. The water-soluble extracts, which are useful in product additives, function to rejuvenate studying approaches and thinking.
Official Online Store - https://www.allnutritionhub.com/get-retro-x-focus-nootropic
How does the Retro X Focus Function?
It is common knowledge that we must work out…